GLP-1 (glucagon-like peptide-1) injections have emerged as a promising tool in the fight against obesity. Originally developed to manage diabetes, GLP-1 receptor agonists, like semaglutide and liraglutide, are now widely recognized for their efficacy in weight loss.
These medications mimic the action of GLP-1, a hormone naturally produced in the gut. GLP-1 plays a crucial role in regulating appetite and food intake. When injected, it enhances the feeling of fullness and slows down gastric emptying, which helps reduce overall calorie intake. Additionally, GLP-1 injections can improve blood sugar control, making them particularly beneficial for individuals with type 2 diabetes.
